According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising the risk for new onset stage 3 or higher chronic kidney disease (CKD), a new study ...

Cancer operations that remove whole or parts of an organ can be life-altering. New research suggests that some patients may ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Prophylactic IV magnesium is associated with a reduced risk for cisplatin-associated acute kidney injury in patients with ...

Telix Pharmaceuticals has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain ...